Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67

ABSTRACT Background: To compare Gleason 7 (3+4) and (4+3) prostatic adenocarcinoma (PC) with different prognostic criteria through immunohistochemical analysis with anti-PSA, anti-Ki 67 and anti-AMARC antibodies. Methods: We analyzed 221 surgical specimens from patients between 40 and 86 years-old...

Full description

Saved in:
Bibliographic Details
Main Authors: Clarice F. E. M. Osório, Waldemar S. Costa, Carla B. M. Gallo, Luciano A. Favorito, Francisco J. B. Sampaio
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2025-01-01
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382025000100405&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542253090865152
author Clarice F. E. M. Osório
Waldemar S. Costa
Carla B. M. Gallo
Luciano A. Favorito
Francisco J. B. Sampaio
author_facet Clarice F. E. M. Osório
Waldemar S. Costa
Carla B. M. Gallo
Luciano A. Favorito
Francisco J. B. Sampaio
author_sort Clarice F. E. M. Osório
collection DOAJ
description ABSTRACT Background: To compare Gleason 7 (3+4) and (4+3) prostatic adenocarcinoma (PC) with different prognostic criteria through immunohistochemical analysis with anti-PSA, anti-Ki 67 and anti-AMARC antibodies. Methods: We analyzed 221 surgical specimens from patients between 40 and 86 years-old (mean=63) with PC. The immunohistochemical study was performed with anti-PSA, anti-Ki 67 and anti-AMARC. The microscopic fields were photographed with an Olympus DP70 digital camera coupled to an Olympus BX51 microscope and archived in TIFF. Proportion and intensity criteria were used to quantify the anti-PSA antibody and for the anti-Ki 67 antibody, the quantification by similarity of this antibody in breast carcinomas. Anti-AMACR protein expression was based on four scores: negative, weak, moderate and strong. The statistical analysis was performed with the Graph Pad Prism 5 program. Results: In the Gleason score 7 (3+4) we had 91.72% in pT2 and 8.27% in the pT3 group; 8.27% recurrences, of which 90.90% in the pT2 group. In the Gleason score 7 (4+3) we had 77.27% in the pT2 group and 22.72% in the pT3 group and 10.22% of relapses, of which 66.66% in the pT2 group and 33.33% in the pT3 group. In 6.81% of cases there was an increase in the anti-Ki 67 index and in 2.27% of the cases, there was an increase in the immunoexpression of anti-p53 when comparing Gleason score 7 (3+4) with Gleason score 7 (4+3). Conclusion: Our study confirmed differences in the Gleason score 7 (3+4) and Gleason score 7 (4+3) of PC when comparing prognostic criteria. Anti-Ki 67 and anti-PSA antibody immunostaining showed a positive correlation as the Gleason score 7 increased from (3+4) to (4+3).
format Article
id doaj-art-92f3f0cbe8354838af49c88fb6992845
institution Kabale University
issn 1677-6119
language English
publishDate 2025-01-01
publisher Sociedade Brasileira de Urologia
record_format Article
series International Brazilian Journal of Urology
spelling doaj-art-92f3f0cbe8354838af49c88fb69928452025-02-04T07:37:16ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-61192025-01-0151110.1590/s1677-5538.ibju.2024.9922Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67Clarice F. E. M. OsórioWaldemar S. CostaCarla B. M. GalloLuciano A. FavoritoFrancisco J. B. Sampaiohttps://orcid.org/0000-0001-9087-9319ABSTRACT Background: To compare Gleason 7 (3+4) and (4+3) prostatic adenocarcinoma (PC) with different prognostic criteria through immunohistochemical analysis with anti-PSA, anti-Ki 67 and anti-AMARC antibodies. Methods: We analyzed 221 surgical specimens from patients between 40 and 86 years-old (mean=63) with PC. The immunohistochemical study was performed with anti-PSA, anti-Ki 67 and anti-AMARC. The microscopic fields were photographed with an Olympus DP70 digital camera coupled to an Olympus BX51 microscope and archived in TIFF. Proportion and intensity criteria were used to quantify the anti-PSA antibody and for the anti-Ki 67 antibody, the quantification by similarity of this antibody in breast carcinomas. Anti-AMACR protein expression was based on four scores: negative, weak, moderate and strong. The statistical analysis was performed with the Graph Pad Prism 5 program. Results: In the Gleason score 7 (3+4) we had 91.72% in pT2 and 8.27% in the pT3 group; 8.27% recurrences, of which 90.90% in the pT2 group. In the Gleason score 7 (4+3) we had 77.27% in the pT2 group and 22.72% in the pT3 group and 10.22% of relapses, of which 66.66% in the pT2 group and 33.33% in the pT3 group. In 6.81% of cases there was an increase in the anti-Ki 67 index and in 2.27% of the cases, there was an increase in the immunoexpression of anti-p53 when comparing Gleason score 7 (3+4) with Gleason score 7 (4+3). Conclusion: Our study confirmed differences in the Gleason score 7 (3+4) and Gleason score 7 (4+3) of PC when comparing prognostic criteria. Anti-Ki 67 and anti-PSA antibody immunostaining showed a positive correlation as the Gleason score 7 increased from (3+4) to (4+3).http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382025000100405&lng=en&tlng=enProstatic NeoplasmsNeoplasm GradingPrognosisHistological Techniques
spellingShingle Clarice F. E. M. Osório
Waldemar S. Costa
Carla B. M. Gallo
Luciano A. Favorito
Francisco J. B. Sampaio
Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
International Brazilian Journal of Urology
Prostatic Neoplasms
Neoplasm Grading
Prognosis
Histological Techniques
title Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
title_full Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
title_fullStr Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
title_full_unstemmed Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
title_short Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
title_sort comparative study of gleason 7 3 4 and 4 3 prostatic adenocarcinomas with prognostic criteria and immunohistochemical profiles of amacr psa and ki 67
topic Prostatic Neoplasms
Neoplasm Grading
Prognosis
Histological Techniques
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382025000100405&lng=en&tlng=en
work_keys_str_mv AT claricefemosorio comparativestudyofgleason734and43prostaticadenocarcinomaswithprognosticcriteriaandimmunohistochemicalprofilesofamacrpsaandki67
AT waldemarscosta comparativestudyofgleason734and43prostaticadenocarcinomaswithprognosticcriteriaandimmunohistochemicalprofilesofamacrpsaandki67
AT carlabmgallo comparativestudyofgleason734and43prostaticadenocarcinomaswithprognosticcriteriaandimmunohistochemicalprofilesofamacrpsaandki67
AT lucianoafavorito comparativestudyofgleason734and43prostaticadenocarcinomaswithprognosticcriteriaandimmunohistochemicalprofilesofamacrpsaandki67
AT franciscojbsampaio comparativestudyofgleason734and43prostaticadenocarcinomaswithprognosticcriteriaandimmunohistochemicalprofilesofamacrpsaandki67